AJU Life Science Overseas Expansion Platform Fund Overview
AJU Life Science Overseas Expansion Platform Fund General Information
Description
AJU Life Science Overseas Expansion Platform Fund is a 2013 vintage buyout fund managed by AJU IB Investment. The fund is located in Seoul, South Korea. The fund targets life sciences, pharmaceuticals and biotechnology sectors.
Contact Information
Fund Manager's Location
- 201, Teheran-ro
- Gangnam-gu
- Seoul
- South Korea
AJU Life Science Overseas Expansion Platform Fund Investments (20)
AJU Life Science Overseas Expansion Platform Fund has made a total of 20 investments. Its most recent deal was a Amphivena Therapeutics for . The deal was made on 24-Sep-2019.
withCompany Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Amphivena Therapeutics | 24-Sep-2019 | Biotechnology | Generating Revenue | |||
TiBit Communications | 22-Aug-2019 | Connectivity Products | Generating Revenue | |||
RAPT Therapeutics | 18-Jun-2019 | Drug Discovery | Clinical Trials - Phase 1 | |||
Kymera Therapeutics | 13-Nov-2018 | Biotechnology | Generating Revenue | |||
Kukka | 04-Sep-2018 | Early Stage VC (Series A) | Other Services (B2C Non-Financial) | Generating Revenue |
AJU Life Science Overseas Expansion Platform Fund Investment Strategy
AJU Life Science Overseas Expansion Platform Fund Limited Partners (5)
Korea Finance is one of AJU Life Science Overseas Expansion Platform Fund’s 5 limited partners. Its latest Original was on 01-Jan-2014.
Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
---|---|---|---|---|---|
Korea Finance | Former | 01-Jan-2014 | Original | ||
Korea Scientists & Engineers Mutual-aid Association | Current | 01-Jan-2014 | Original | ||
Military Mutual Aid Association | Current | 01-Jan-2014 | Original | ||
Sam Chun Dang Pharm | Current | 01-Jan-2014 | Original | ||
Shinhan Capital | Corporation | Current | 01-Jan-2014 | Original |
AJU Life Science Overseas Expansion Platform Fund Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
AJU Life Science Overseas Expansion Platform Fund Benchmark (28)
Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
---|---|---|---|---|---|
Jupiter Sri Lanka Growth Fund | |||||
Excelsior Capital Asia Partners IV | 30-Jun-2023 | ||||
Myanmar Opportunities Fund I | |||||
Nepoch Capital China Buyout Fund I | |||||
Ambit Pragma Fund II | |||||
Abraaj Pakistan Fund I | |||||
Mongolia SME | |||||
Aria Investment Partners IV | |||||
Mizuho ASEAN Private Equity Fund | |||||
Falcon House Partners Indonesia Fund I |
AJU Life Science Overseas Expansion Platform Fund FAQs
-
What is AJU Life Science Overseas Expansion Platform Fund?
AJU Life Science Overseas Expansion Platform Fund is a 2013 vintage buyout fund managed by AJU IB Investment.
-
Who manages AJU Life Science Overseas Expansion Platform Fund?
AJU Life Science Overseas Expansion Platform Fund is managed by AJU IB Investment.
-
Where is AJU Life Science Overseas Expansion Platform Fund domiciled?
AJU Life Science Overseas Expansion Platform Fund is domiciled in South Korea.
-
What is AJU Life Science Overseas Expansion Platform Fund's size?
AJU Life Science Overseas Expansion Platform Fund has a size of
. -
What type of fund is AJU Life Science Overseas Expansion Platform Fund?
The fund type of AJU Life Science Overseas Expansion Platform Fund is Buyout.
-
What is the status of AJU Life Science Overseas Expansion Platform Fund?
AJU Life Science Overseas Expansion Platform Fund is closed.
-
What has AJU Life Science Overseas Expansion Platform Fund invested in?
AJU Life Science Overseas Expansion Platform Fund has made numerous investments in companies like Amphivena Therapeutics, TiBit Communications, and RAPT Therapeutics within the Biotechnology, Connectivity Products, and Drug Discovery industries.
-
What has AJU Life Science Overseas Expansion Platform Fund invested in recently?
AJU Life Science Overseas Expansion Platform Fund's latest investment was on 24-Sep-2019 in Amphivena Therapeutics, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »